ProQinase + Reaction Biology = your partner for drug discovery

A new value equation: ProQinase and Reaction Biology have come together to serve you with a comprehensive drug discovery service portfolio comprising biochemical, biophysical and cellular assays as well as animal testing models. In addition, we offer hundreds of recombinant kinases and epigenetic proteins.

We are the leading CRO for kinase and epigenetic inhibitor discovery with a focus on oncology now serving more than 1,500 clients globally.

For special project requests our PhD level scientists will share their expertise to work together with you to design the best project setup and assay protocol to move forward. Our broad portfolio offers the opportunity to get end-to-end service and to partner with us for integrated drug discovery projects.

Your ProQinase team.

Latest News

09-Jul-2019 Next meetings

We would be delighted to meet you on one of the following scientific conferences: • Discovery on Target , Boston, MA, USA | September 16-19 • EORTC-NCI-AACR , Boston, MA, USA | October 26-30 • ELRIG "Drug Discovery" , Liverpool, UK | November 5-6 Stay tuned...

Newsletter

Stay informed/Get special offers